{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:36:22Z","timestamp":1769556982068,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.urology.2011.09.006","type":"journal-article","created":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T23:00:46Z","timestamp":1320447646000},"page":"240.e9-240.e15","source":"Crossref","is-referenced-by-count":18,"title":["Utility of Urothelial mRNA Markers in Blood for Staging and Monitoring Bladder Cancer"],"prefix":"10.1016","volume":"79","author":[{"given":"Mercedes","family":"Mar\u00edn-Aguilera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Mengual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ribal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Ars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"G\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2011.09.006_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.urology.2004.10.048","article-title":"Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?","volume":"65","author":"Hong","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.09.006_bib2","first-page":"577","article-title":"Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients","volume":"7","author":"Gazzaniga","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/01.ju.0000118648.29024.b7","article-title":"Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer","volume":"171","author":"Okegawa","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.09.006_bib4","first-page":"3166","article-title":"Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer","volume":"6","author":"Lu","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib5","first-page":"411","article-title":"Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging","volume":"26","author":"Ribal","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.diagmicrobio.2006.04.010","article-title":"Comparison of real-time reverse transcriptase-polymerase chain reaction and nested or commercial reverse transcriptase-polymerase chain reaction for the detection of hepatitis E virus particle in human serum","volume":"56","author":"Ahn","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.urology.2011.09.006_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-0500-1-21","article-title":"Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays","volume":"1","author":"Mengual","year":"2008","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.urology.2011.09.006_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.eururo.2008.04.059","article-title":"Molecular lymph node staging in bladder urothelial carcinoma: impact on survival","volume":"54","author":"Mar\u00edn-Aguilera","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.09.006_bib9","series-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2002"},{"key":"10.1016\/j.urology.2011.09.006_bib10","series-title":"Tumours of the Urinary System and Male Genital Organs","article-title":"World Health Organization Classification of Tumours","author":"Lopez-Beltran","year":"2004"},{"key":"10.1016\/j.urology.2011.09.006_bib11","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1097\/01.ju.0000181214.32390.75","article-title":"Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20","volume":"174","author":"Wu","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.09.006_bib12","first-page":"1516","article-title":"Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder","volume":"7","author":"Seraj","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib13","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1158\/1078-0432.CCR-04-2297","article-title":"Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for focally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II","volume":"11","author":"Kurahashi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-5347(05)67418-6","article-title":"Detection of hematogenous micrometastasis in patients with transitional cell carcinoma","volume":"164","author":"G\u00fcdemann","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.09.006_bib15","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.urology.2011.09.006_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2011.09.006_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3816\/CBC.2007.n.004","article-title":"Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden","volume":"7","author":"Cristofanilli","year":"2007","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.urology.2011.09.006_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymeth.2010.01.027","article-title":"Circulating tumour cells in clinical practice: methods of detection and possible characterization","volume":"50","author":"Alunni-Fabbroni","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.urology.2011.09.006_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ctrv.2008.11.003","article-title":"Detection of circulating tumor cells in bladder cancer patients","volume":"35","author":"Nezos","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.urology.2011.09.006_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1349-7006.1999.tb00811.x","article-title":"Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction","volume":"90","author":"Fujii","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/cncr.22543","article-title":"Detection of circulating urothelial cancer cells in the blood using the CellSearch System","volume":"109","author":"Naoe","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2011.09.006_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.urology.2011.09.006_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1354393","article-title":"Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction","volume":"257","author":"Liang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.urology.2011.09.006_bib24","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1158\/1078-0432.CCR-04-0166","article-title":"The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer","volume":"10","author":"Patel","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nature06385","article-title":"Isolation of rare circulating tumour cells in cancer patients by microchip technology","volume":"450","author":"Nagrath","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.urology.2011.09.006_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-5347(05)66067-3","article-title":"Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy","volume":"166","author":"Mills","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.09.006_bib27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2003.05.101","article-title":"Radical cystectomy for bladder cancer today\u2014a homogeneous series without neoadjuvant therapy","volume":"21","author":"Madersbacher","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.09.006_bib28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.ju.0000052721.61645.a3","article-title":"Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base","volume":"169","author":"Konety","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.09.006_bib29","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1158\/1078-0432.CCR-05-2081","article-title":"Novel blood biomarkers of human urinary bladder cancer","volume":"12","author":"Osman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2011.09.006_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.urolonc.2008.03.019","article-title":"Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder","volume":"27","author":"Kouba","year":"2009","journal-title":"Urol Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511023533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511023533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T21:50:23Z","timestamp":1543441823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429511023533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0090429511023533"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2011.09.006","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}